A morpho-molecular prognostic model for hepatocellular carcinoma

British Journal of Cancer

Volumn 107, Issue 2, 2012, Pages 334-339

  Srivastava, S ^a   Wong, K F ^a   Ong, C W ^a,b   Chan, Yiong Huak ^b   Yeoh, K G ^b   Teh, M ^b   Luk, J M ^a,b   Salto Tellez, M ^b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

liver cancer; microvessel density; p53; prognosis; survival

Indexed keywords

ALPHA FETOPROTEIN; BETA CATENIN; CD44V ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; HERMES ANTIGEN; KI 67 ANTIGEN; PROTEIN P53; STEM CELL FACTOR RECEPTOR; UVOMORULIN;

ADULT; ALGORITHM; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CARCINOGENESIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE DURATION; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; TISSUE MICROARRAY;

ALPHA-FETOPROTEINS; ANTIGENS, CD31; ANTIGENS, CD44; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84863718483     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.230     Document Type: Article

References (25)

1. Boyault S, Rickman DS, de Reynies A (2007) Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 45: 42-52
2. Burchard J, Zhang C, Liu AM, Poon RT, Lee NP, Wong KF, Sham PC, Lam BY, Ferguson MD, Tokiwa G, Smith R, Leeson B, Beard R, Lamb JR, Lim L, Mao M, Dai H, Luk JM (2010) MicroRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol Syst Biol 6: 402
3. Chen XP, Qiu FZ, Wu ZD, Zhang ZW, Huang ZY, Chen YF (2006) Long term outcome of resection of large hepatocellular carcinoma. Br J Surg 93(5): 600-606
4. Das K, Mohd Omar MF, Ong CW, Bin Abdul Rashid S, Peh BK, Putti TC, Tan PH, Chia KS, Teh M, Shah N, Soong R, Salto-Tellez M (2008) TRARESA: tissue microarray-based hospital system for biomarker validation and discovery. Pathology 40: 441-449
5. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 7: 462-503
6. Endo K, Terada T (2000) Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression and patient survival. J Hepatol 32: 78-84
7. Frachon S, Gouysse G, Dumortier J, Couvelard A, Nejjari M, Mion F, Berger F, Paliard P, Boillot O, Scoazec JY (2001) Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study. J Hepatol 34: 850-857
8. Giatromanolaki A, Koukourakis M, O'Byrne K, Fox S, Whitehouse R, Talbot DC, Harris AL, Gatter KC (1996) Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol 79: 80-88
9. Heagerty PJ, Lumley T, Pepe MS (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56: 337-344
10. Hoshida Y, Nijman SM, Kobayashi M, Chan JA, Brunet JP, Chiang DY, Villanueva A, Newell P, Ikeda K, Hashimoto M, Watanabe G, Gabriel S, Friedman SL, Kumada H, Llovet JM, Golub TR (2009) Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res 69: 7385-7392
11. Hu TH, Huang CC, Lin PR, Chang HW, Ger LP, Lin YW, Changchien CS, Lee CM, Tai MH (2003) Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Cancer 97(8): 1929-1940
12. Kawai HF, Kaneko S, Honda M, Shirota Y, Kobayashi K (2001) a-fetoprotein-producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis. Hepatology 33: 676-691
13. Lai CL, Ratziu V, Yuen MF, Poynard T (2003) Viral hepatitis B. Lancet 362: 2089-2094
14. Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T, Durnez A, Demetris AJ, Thorgeirsson SS (2004) Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 40: 667-676
15. Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19: 329-338
16. Luk JM, Lam CT, Siu AF, Lam BY, Ng IO, Hu MY, Che CM, Fan ST (2006) Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp 27, Hsp 70, GRP 78) up-regulation and their associated prognostic values. Proteomics 6(3): 1049-1057
17. Parkin DM (2000) Global cancer statistics in the year 2000. Lancet Oncol 2: 533-543
18. Qin LX, Tang ZY (2004) Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: A review of the literature. J Cancer Res Clin Oncol 130: 187-196
19. Sobin LH, Wittekind C (2002) UICC (International Union against Cancer). TNM Classification of Malignant Tumors, 6th edn, pp 1-264. John Wiley & Sons Inc: New York
20. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, Curley SA, Ellis LM, Regimbeau JM, Rashid A, Cleary KR, Nagorney DM. (2002) Simplified staging for hepatocellular carcinoma. J Clin Oncol 20: 1527-1536
21. World Health Organization. Mortality Database. WHO Statistical Information System. Available from URL http://www.who.int/whois
22. Yamashita T, Forgues M, Wang W, Kim JW, Ye Q, Jia H, Budhu A, Zanetti KA, Chen Y, Qin LX, Tang ZY, Wang XW (2008) EpCAM and afetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res 68(5): 1451-1461
23. Yang XR, Xu Y, Yu B, Zhou J, Qiu SJ, Shi GM, Zhang BH, Wu WZ, Shi YH, Wu B, Yang GH, Ji Y, Fan J (2010) High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma. Gut 59: 953-962
24. Zhang D, Salto-Tellez M, Putti TC, Do E, Koay ES (2003) Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer. Mod Pathol 16(1): 79-85
25. Zlobec I, Steele R, Terracciano L, Jass JR, Lugli A (2007) Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol 60: 1112-1116